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Abstract
Kupffer cells, which have a characteristic morphology and a kind of phenotype, are the 
resident macrophages in liver, serve as the largest population mononuclear phagocytes 
in the body, and are localized in the periportal zone. They have phagocytosis capacity 
and release all kinds of cytokines, chemokines, and soluble biological mediators. Owing 
to the different functions of Kupffer cells, they play an important role in liver diseases. In 
this chapter, we review the role of Kupffer cells in infectious disease, fatty liver  disease, 
liver fibrosis, liver ischemia-reperfusion injury, liver transplantation immunology, as 
well as liver cancer and metastases.
Keywords: Kupffer cell, infectious disease, fatty liver disease, fibrosis, ischemia-
reperfusion injury, liver transplantation immunology, liver cancer, metastases
1. Introduction
Kupffer cells (KCs), as the largest population mononuclear phagocytes in the body, account for 
80–90% of the total number of natural macrophages and 20% of the liver nonparenchymal cells 
[1]. They form a self-renewing pool of organ-resident macrophages independent of the myeloid 
monocyte compartment and derive from resident stem cells which originate from the fetal yolk 
sac before [2–4]. Other studies also found that KCs derived from embryonic progenitors colonize 
the tissues before birth [5–11], but with the growth of mouse, bone marrow-derived monocytes 
will fill up additional macrophage niches that become available, competing with the resident 
population. This situation occurs in the liver and spleen, but not in the brain and lung [12].
KCs have a characteristic morphology with amoeboid lamellipodia and an irregular surface 
containing many microvilli [13], located at the luminal side of liver sinusoidal endothelium or 
© 2017 The Author(s). Licensee InTech. This chapt r is distributed under the terms of the Creative Comm s
Attribution L cense (http://creativecommons. /licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
the lamellipodia extended into the Disse space through the fenestrae. This is an ideal position 
for their main function in the liver. This state can filter the blood that enters the liver from both 
the portal vein and the hepatic artery, which is an important part of the cellular immunity sys-
tem of the mammalia (Figure 1). So, the structure of KCs plays a role in the mutual  coordination 
and influence of liver parenchymal cells and other nonparenchymal cell functions and makes 
up these cells’ important versatile constituents of the liver [14–16]. Now, according to the func-
tion of KCs, they could be distinguished as two groups: the one with higher phagocytosis capac-
ity and the other with preference toward cytokines and  chemokines production [17, 18]. Some 
studies found that there were large KCs in rats. They are localized in the periportal zone and 
have increased phagocytosis and increased production of biological mediators. These large 
KCs can be identified by the expression of CD163, also described as ED2 antigen, which is a 
scavenger receptor [19]. KCs (Table 1) can also be identified by the expression of CD68 (ED-
1); they were called small KCs in rats. The general macrophage marker F4/80 or by ED-1 was 
expressed on the surface of mice KCs, which is present in all KCs regardless of their location 
[20]. In mice, KCs can be distinguished from monocytes among the F4/80+ cells as Ly6C low 
CD11b  low-cell population [21, 22]. Additionally, macrophages are functionally grouped into 
two classes, M1 and M2. M1 (termed classically activated) macrophages are pro-inflammatory 
and could produce pro-inflammatory cytokines and chemokines, while the M2 (termed alterna-
tively activated) macrophages are suppressive and involved in cellular repair [23]. According to 
this situation, KCs as one kind of macrophages also have these functions and play a fundamen-
tal role in homeostasis and diseases [24]. KCs also have a unique KCs gene Clec4f to distinguish 
with other macrophage; Clec4F has been previously described as a KCs-specific marker [25–27].
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portal vein
hepatic artery
bile duct
KC
central vein
Hepatocytes
Figure 1. Schematic representation of the liver microanatomical structure and Kupffer cell localization in lower 
magnification.
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In vivo, under steady condition, the KCs are resting situation; they play a role in eliminating 
macromolecules, immune complexes, toxins, and degenerated cells from circulation. Pattern 
recognition receptors (PRRs) on the KCs are the main factor to eliminate the debris, toxins, 
and insoluble macromolecules, such as scavengers receptors (CDl3, CD14, CDl5, and CD68, 
CD163), mannose receptors, Fc receptors (including CD64, CD32, and CDl6), complement 
receptor (including the complement receptor L, complement receptor 3, and complement 
receptor 4), I region-associated antigen, which are able to bind to toxins lipopolysaccharide 
(LPS), immune complexes, or opsonized cells [28]. Since KCs reside in the liver sinusoids in 
large numbers and are adherent to the endothelial cells, they are able to sample the blood 
entering the liver from the gut as well as from the main circulation. KCs also could remove the 
senescent or damaged erythrocytes. In this process, following phagocytosis and hemolysis, 
KCs could express HO (including HO-1, HO-2, and HO-3) to degrade hemoglobin, which is 
part of  erythrocytes  component. HO-1 catalyzes the degradation of heme into iron, biliver-
din, and carbon  monoxide, which are all considered to be hepatoprotective at low quantities 
under steady-state conditions [29, 30]. 
Pathogen- and damage-associated molecular patterns (PAMPs and DAMPs, respectively) 
were two kinds of PRRs to express on the surface of KCs. They included multiple fami-
lies, such as Toll-like, RIG-like, and NOD-like receptors (TLR, RLR, and NLR, respectively), 
and C-type lectin receptors (CLR) [31]. Mouse KCs can express TLR1-TLR9, all of which 
appear to be functional [32]. Human KCs, so far, have only been described to express TLR2, 
TLR3, and TLR4 [33, 34]. Furthermore, in the Listeria monocytogenes (Lm) infection model, 
mouse KCs are shown to express RIG-like receptor I [35]. Hepatocytes and CD68+ liver 
mononuclear cells (presumably KCs) express NLRC2 (NOD2) [36]. When the KCs were 
activated by the emergence of endotoxins and harmful exogenous particles from the portal 
vein and  circulation, their functions were enhanced. They could produce all kinds of cyto-
kines and chemokines significantly. In the presence of TLR ligands, such as LPS and CpG, 
Origin Marker PRR PAMP DAMP Immunogenic Polarization of 
macrophages
Rat Derived from 
the fetal yolk 
sack and 
embryonic 
progenitors 
colonize the 
tissues. Liver-
resident Express 
Clec4F gene
CD68/ED1 
CD163/ED2
Scavengers 
receptors (CDl3, 
CD14, CDl5, CD68, 
CD163) Mannose 
receptors Fc 
receptors (CD64, 
CD32, CDl6) 
Complement 
receptor (CR1, 
CR3, CR4) I region-
associated antigen
TLR1-TLR9 
NLR
MHC-II CD80 
CD86 PDL-1 
(CD274)
M1 Pro-
inflammatory 
antitumoral
Mouse F4/80 CD68 
CD11blow
TLR1-TLR9 
NLR RLR
M2 Anti-
inflammatory 
Immune 
suppressive 
protumoralHuman CD68 CD14 TLR2 TLR3 TLR4 NLR
Table 1. This table is used for KC identification and major surface receptors and moleculars involved in the function in 
human, mouse, and rat.
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the  CD14-positive KCs were stimulated by TLR4, which activates the intracellular signal 
 pathway via myeloid  differentiation factor 88 (MyD 88), resulting in NF-κB activation to 
produce the pro-inflammation cytokines IL-6, TNF-α, IL-1β, ICAM-1, VCAM-1, and VAP-1 
[37], and the CD14  expression on KCs is increased [31]. CD14-transgenic mice that overex-
press CD14 on monocytes have increased sensitivity to LPS [38]. As a receptor of dsRNA, 
TLR3 on KCs is one of the primary triggers in the defense of viral diseases. TLR3 activation 
induces the strongest IFN-γ response. KCs were activated presumably due to the induction 
of IL-12 in the absence of IL-10 coproduction, which was observed upon TLR2 and TLR4 
ligation [39]. Activation of TLR7 triggers the secretion of type I interferons and activation of 
subsequent genes encoding CXCL10, CXCL11, Mx1 (antiviral G-Protein), CCL2 (also known 
as MCP-1), also secretion of IL-10, leading to enhanced viral clearance [40]. TLR9 activation 
on KCs attenuates inflammation by the secretion of IL-10, suppressing the activation of infil-
trating monocyte-derived macrophages in mice. This finding supports a dual role of TLR9 
engagement, which depends on the target T-cell type [41]. LPS, DNA, SFA, amyloid cho-
lesterol, cathepsin κ, and reactive oxygen species (ROS) and so on have been suggested as 
NLPR3 activators, which comprise the NOD-like receptor NLRP3, the apoptosis-associated 
speck-like protein containing a caspase recruitment domain, and the effector molecule pro-
caspase inflammation [42]. 
KCs likely derived from infiltrating monocytes express MHC-II antigens and costimula-
tory molecules (CD80 and CD86), which can present foreign antigens to the reactive 
T cells, induced T cell responses, and thus conferred tolerance to induce regulatory T cells in 
immune response [28]. IL-10 and PDL-1 (also known as CD274) participated in the immune 
tolerance, which reduce the antigen-presenting capacity of KCs by downregulating the 
expression of MHC molecules and costimulators, but without strongly affecting the scaven-
ger function of KCs. 
KCs not only can interact with T cells but can also interact with many cellular components 
in the liver. For instance, KCs can initiate the recruitment of other monocytes to the liver 
in case of injuries, which is important for liver regeneration, and they also interact with 
hepatic stellate cells (HSCs) to play a role in liver diseases and repair [43, 44]. TLR4 signal on 
KCs indirectly silences patrolling NK cells by MYD88-dependent IL-10 secretion, whereas 
TLR2 or TLR3 induces IL-18 and IL-1β, leading to NK-cell activation in liver inflammation 
[45]. Traditionally, M1 macrophage phenotype is marked by the release of pro-inflamma-
tory cytokines like TNF-κ, IL-1, and IL-12. Alternative activation of M2 phenotype is more 
heterogeneous, as different stimuli are main to release anti-inflammation cytokines (such 
as IL-10). Typically, the increased expression of arginase 1, the secretion of immune-mod-
ulatory cytokines (such as IL-10 and TGF-κ), and the involvement in tissue repair phase 
are considered as indicators of M2 macrophage differentiation. Different origin of the cells 
together with the functional plasticity of macrophages can explain the phenotypic and func-
tional heterogeneity of KCs observed upon different triggers of liver pathology [46, 47]. On 
the basis of these concepts, in the next sections, we summarize the role of KCs to various 
diseases involving the liver, in particular infectious disease, fatty liver disease, liver fibrosis 
and cirrhosis, ischemia and reperfusion (I/R) injury, liver cancer as well as liver transplanta-
tion immunology (Figure 2).
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2. Kupffer cells in infectious disease
KCs and the sinusoidal endothelial cells are the first barriers for pathogens to enter the liver 
via the portal vein [48]. Their endocytic capacity, the expression of different PRRs, MHC, 
and costimulatory molecules, and the ability to produce a variety of physiologically active 
substances (mediators of the inflammatory process) when they were stimulated make them 
as the potent immune cells that aim to either pathogen clearance or persistence. The liver is 
constantly exposed to non–self-protein which is derived from nutrients or microbiota, and 
bacterial endotoxins would trigger immune response to induce inflammation. These patho-
gens may activate KCs that lead to produce anti-inflammation cytokines and chemokines 
for the inhibition of pathogen replication, or recruit and activate other immune cells to liver 
to participate in the inflammation reaction. So the inflammation process is a multifactor and 
multicell interaction to participate in. In this process, KCs can recruit other immune cells 
such as  monocytes into the liver, which are then polarized into regulatory IL-10+IL-12−DCs by 
hepatocyte growth factor [49], macrophage colony-stimulating factor (M-CSF) [50], through 
inducing activation of the signal of STAT3 and SMAD, then blocking NF-κB [51], and then 
producing anti-inflammation cytokines. At the same time, stimulation of the body-wide 
DCs response by the administration of Fms-related tyrosine kinase 3 ligand (Flt3L), granu-
locyte colony-stimulating factor (G-CSF), or granulocyte-macrophage colony-stimulating 
factor (GM-CSF) reverses endotoxin-related immunoparalysis that probably over produces 
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Figure 2. KCs interact with other cells in liver diseases and have the bidirectional function.
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unprimed myeloid cells, which in turn are capable of developing into TNF-IL-12-DCs after 
stimulation with LPS and other pathogens [52]. This approach may effect on patients with 
acute-on-chronic liver failure to overcome immunoparalysis [53]. 
NK cells are important during liver inflammation, TLR2 or TLR3 signal on KCs are activated 
to induce cytokines IL-18 and IL-1β production, then lead to NK cells activation to immune 
responses [54]. The chemokine CXCL16 secretion from KCs could guide the CXCR6+  NKT-cell 
trafficking in the liver to regulate immune responses during microbial infection, and KCs 
might interact with patrolling NKT cells via glycolipid receptors such as CD1d to produce 
pro-inflammation cytokines IL-4, IFN-γ, and then provide cytotoxic activity [55–57]. When 
KCs were activated, they become immunogenic to induce CD8 T cells activation, and the 
generation of efficient CLT response [58, 59]. Thus, during liver infection, KCs support the 
development of antimicrobial T cell responses. Besides CD8 T cells responses, recent studies 
describe that naive CD4 T cells also could be activated in the murine liver disease [60]. 
The interaction of KCs with membrane-bound as well as soluble mediators expressed by 
infiltrating immune cells probably leads to further regulation of KCs function. Several stud-
ies have reported the involvement of adhesion molecule vascular endothelial growth factor-1 
(VEGF-1), which is expressed by KCs, in liver inflammation. In common with endothelial 
cells which express both VCAM-1 and VEGF-Rs, KCs also could express several antigens 
that functionally regulate the bioactivities of KCs, including cytokine activation and produc-
tion, cytoskeleton rearrangement, survival, and chemotaxis in liver inflammation [61–68]. 
The infiltration of neutrophils is commonly seen in all types of liver disease, especially in 
liver inflammation [69]. Neutrophils also could activate KCs and endothelial cells, leading to 
upregulation of cellular adhesion molecules such as ICAM-1, VCAM-1, or VAP-1 to induce 
neutrophils infiltration and endocytose the microbe [70]. Furthermore, KCs might play a dual 
effect in liver inflammation, and pathogens may exploit the tolerogenic capacities of KCs to 
evade immunity and may have evolved to inhibit the immunogenic functions of KCs. Then, 
we provide examples of the various roles of KCs in bacterial, viral, and parasitic infection.
2.1. Liver infection by bacteria
Kupffer cells act as sentinels capturing antigens and pathogens and are key contributors 
of host defense against enteroinvasive bacteria [5]. L. monocytogenes (Lm) is a very well-
characterized facultative intracellular model microorganism [71]. Lm, which could be cap-
tured by KCs, triggers a massive recruitment of monocytes leading to the formation of liver 
Lm-containing microabscesses 2–3 days post inoculation [72]. These microabscesses contain 
M1 macrophages, TNF/iNOS-producing dendritic cells (Tip-DCs), and neutrophils to play a 
critical role in the rapid control of the infection [73, 74]. Infected KCs secrete inflammation 
mediators such as IL-1β and IL-4 to inhibit proliferation of the microorganism [75]. At the 
same time, infected KCs could secret chemokines such as MIP-1α (CCL3), MIP-1β (CCL4), 
MCP-1 (CCL2), and MIP-2 (CXCL2/-3), leading to “pro-inflammatory” M1 macrophages that 
express the chemokine receptor CCR2 recruitment to the liver, which egress from the bone 
marrow, then control the infection [76, 77]. But some studies indicate that KCs undergo a 
rapid necroptotic death upon the first hours of their infection by Lm. KCs necroptosis triggers 
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hepatocytes to release the alarmin interleukin-33 (IL-33), which triggers basophil IL-4 pro-
duction [78], then in turn causes recruited monocyte-derived macrophages to proliferate and 
shift from an M1 to M2 phenotype. This allows ultimately the replacement of dead KCs by 
M2 macrophages after Lm infection. During infection with Lm, tissue-resident KCs are quan-
titatively replaced by monocytes, which develop into tissue-resident macrophages. The lethal 
irradiation also led to the replacement of embryo-derived KCs by bone-marrow-derived 
macrophages, which acquired a highly similar cell identity as indicated by the adoption of 
a KCs characteristic global enhancer landscape. Initially, these cells contribute to antibacte-
rial immunity in a typical IFN-γ-driven inflammatory response. In the second phase, KCs 
necroptosis also initiates a cascade of IL-4-driven events inducing proliferative expansion 
and phenotypic changes of monocyte-derived macrophages that promote restoration of tis-
sue integrity after bacterial clearance. Similar results were obtained with the enteroinvasive 
bacterium of Salmonella enterica [79]. This is a new field of investigations for infection control 
and tissue return to homeostasis. 
When liver infection with Francisella tularensis occurs, it is able to infect and replicate within 
Kupffer cells which release pro-inflammatory cytokines TNFα, IL-1β, and IL-6, leading to 
sepsis [80]. But hepatocytes as well as dendritic cells may support the intracellular replication 
of F. tularensis without undergoing proptosis or apoptosis, because the hepatocytes could 
release chemokines FKN to reverse this process [81, 82]. So, KCs inactivation or depletion 
results in impaired bacterial clearance. Although KCs play a critical role in infection, various 
studies indicate that the actual elimination of the bacteria taken up by the liver depends on a 
complex interaction of KC and other inflammation cells.
2.2. Liver infection by viruses
Both hepatitis B virus (HBV) and hepatitis C virus (HCV) are blood-borne viruses, when 
infected by them can result in chronic liver disease with an increased risk for liver fibro-
sis/cirrhosis, hepatic failure, and liver cancer [83, 84]. Studies suggested that hepatic macro-
phages played an important role in viral hepatitis. KCs have a beneficial antiviral effect on 
the early phase after infection. During systemic viral infection, liver resident KCs are essen-
tial for the efficient capture of the virus and preventing viral replication. The next involves 
fast induction of an antiviral status in KCs by producing IFN-γ and prevents viral spread to 
neighboring hepatocytes [85, 86]. Activated KCs express high levels of immunogenic MHC 
II and can thereby activate virus-specific CD4+ T cells in liver; CD4+ T cells also can produce 
IFN-γ in response to antigen exposure. At the same time, under an antiviral status, this might 
enhance the phagocytic capacity of KCs, which might additionally contribute to control 
virus  replication [87, 88]. Some studies make use of a short-term LCMV-Cl13 infection in 
mice to  examine phenotypic and functional changes in inflammatory monocytes and F4/80-
high-Kupffer cells instead of virus infection animal models; these cells are the first innate 
immune cells to encounter a viral pathogen in liver. They observed F4/80-high-Kupffer cells, 
which maintain their endocytic activity and increase the expression of several pro- and anti-
inflammatory cytokines and chemokines after LCMV infection. KCs from LCMV-infected 
mice clearly show the induction of pro- and anti-inflammatory cytokines and chemokines, 
The Biological Function of Kupffer Cells in Liver Disease
http://dx.doi.org/10.5772/67673
59
including TNF, IL-6, IL-10, MCP, CXCL-10, and others. The active uptake of LCMV by KCs 
limits viral spread and immunopathology [89, 90].
In human body, when they are infected by HBV particles and HBs, the virus induces IL-1β, 
IL-6, IL-18, CXCL8, and TNF production by human CD68+ KCs via NF-кB activation leading 
to NK cell activity and then NK cells produce IFN-γ, which plays an important role in anti-
viral immunity. 
KCs have two functional AIM2 and NLRP3 inflammasomes, and that AIM2 production of 
IL-1β and IL-18 is essential for IL-8 transcription as well as activating liver and peripheral 
blood NK cells, respectively [91, 92]. Some studies demonstrated that rat ED1+-adherent 
KCs exposed to HBV virus hardly expressed IL-1β, IL-6, or TNF, but produced the immuno-
regulatory cytokine TGF-β, because hepatitis B surface Ag blocks IRF7 binding to the AIM2 
promoter. Targeting AIM2 prevents the recognition of dsDNA expressed by the HBV, and 
that the limited innate response observed upon HBV infection may be due to viral-mediated 
immune evasion [93, 94]. Another link between hepatic inflammation and disease in patients 
with chronic HCV was attributed to IL-1β secretion following the activation of the NLRP3 
inflammasome in liver macrophages (CD68+/CD14+) [95]. 
Chronic infection associated with hepatitis B virus (HBV) is a major cause of liver fibrosis and 
cirrhosis. The activation of NADPH oxidase during the phagocytosis of HBV particles, and 
signal transducers and activators of transcription-3 (STAT-3) binding to elements in the TGF-β 
promoter may also be involved to increase TGF-β production. So KCs could produce the pro-
fibrogenic/anti-inflammatory cytokine TGF-β rather than the pro-inflammatory cytokines 
IL-6, IL-1, and TNF-α. This may partly explain why overt liver fibrosis is still present when 
chronic hepatitis B virus infection occurs with minimal (or no) necroinflammation [93, 96, 97]. 
KCs in the HBs-Tg mice expressed higher level of CD205 and produced greater amounts of 
interleukin (IL)-12 than did those in the WT mice. Depletion of KCs, neutralization of IL-12, 
or specific silencing of CD205 on KCs significantly inhibited CpG-oligodeoxynucleotides 
 (CpG-ODN)-induced liver injury and NKT cells activation in the HBs-Tg mice. These data 
CD205-expressing KCs respond to CpG-ODNs and subsequently release IL-12 to promote 
NKT cell activation. Activated NKT cells induce liver damage through the Fas-signaling 
 pathway in HBs-Tg mice [98]. 
HCV infection also could make KCs and liver-infiltrating lymphocytes the major sources of 
TGF-protein, leading to liver fibrosis [99]. The cellular protein, glucose-regulated protein 94 
(GRP94), which is directly mediated by NF-κB activation to interact with HCV E2, plays an 
important role in TGF-protein induction, suggesting that GRP94 is a potential target for the 
development of drugs that prevent hepatic fibrosis caused by HCV infection. Moreover, TGF 
plays a pivotal role in the generation of Treg cells from precursor cells, such that a GRP94-
inhibiting drug would also likely boost immunity against HCV infection by blocking the 
induction of Treg cells, which direct the immune tolerance against HCV [100, 101]. 
KCs with heme are metabolized and detoxified by heme oxygenase-1 (HMOX1) to carbon 
monoxide (CO), biliverdin, and free iron (which induces ferritin). The HMOX1 and metab-
olites of heme besides possessing anti-inflammatory and antioxidant properties have been 
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noted to have antiviral effects in hepatitis C-infected cell lines. Additionally, these substances 
have been shown to enhance the response to IFN-α by restoring interferon-stimulated genes 
(ISGs) [102]. 
Only few studies on HEV-infected animals and humans have been published. But through 
immunohistochemistry, HEV antigens were detected mainly in KCs and liver sinusoidal 
endothelial cells, partially associated with hepatic lesions and infiltrates of CD3-positive cells. 
Since KCs and liver sinusoidal endothelial cells have antigen-presenting functions, they may 
also play a role in the host defense mechanisms and immunopathogenesis [103, 104].
In contrast to HBV and HCV, infection of HAV is self-limiting and does not induce chronic 
infectious disease. HAV reaches hepatocytes via KCs that bind complexes of HAV- and 
 HAV-specific IgA antibodies via the Fcα receptor [105], and subsequently transfer the virus 
to hepatocytes. Different from HBV and HCV, HAV requires the disruption of host cell mem-
branes to release its progeny. These dying hepatocytes may provide DAMP, which can be 
recognized by KCs and other intrahepatic immune cells, leading to the activation of these 
cells that can overcome viral immune escape and liver-intrinsic tolerogenic mechanisms [106]. 
2.3. Liver infection by parasites
Infection by the Echinococcus larval stages (larval echinococcoses) can affect humans [107], 
which are thus accidental to be intermediate hosts. Intermediate host infection occurs after 
the ingestion of eggs (passed out with the definitive host feces), which hatch releasing 
 oncospheres that penetrate the intestinal wall, and then are carried by blood or lymph to 
organs. Lectins are central players in innate immune to pathogens. A screen among lectins 
known to be expressed in mammalian macrophages identified only the mouse Kupffer cells 
receptor (KCR; CLEC4F) as a lectin able to bind the Echinococcus granulosus LL [108]. KCs in 
particular are known to be tolerogenic, as opposed to conventional priming in the lymph 
nodes draining the organ [52]. Thus, the new data are consistent with the hypothesis that the 
LL carbohydrates are evolutionarily optimized for ensuring the clearance of shed LL particles 
by KCs. This hypothesis includes the possibility that KCR engagement favors the KCs release 
of anti-inflammatory mediators to participate in the infectious process to alleviate the liver 
injury [109–111]. 
Infection by the protozoan parasite Entamoeba histolytica causes hepatocyte damage in focal 
areas leading to amebic liver abscess (ALA). Selective depletion of KCs using liposome-
entrapped clodronate or the inhibition of monocytes infiltration using CCR22/2 mice revealed 
that KCs and inflammatory Ly-6Chi monocytes, through producing TNF-α, are the main 
effector cells responsible for liver destruction during ALA [112]. 
KCs also represent the port of liver entry for Plasmodium and Leishmania, which parasit-
ize KCs and then infect other liver cells [113]. Parasites enter into the skin after a mosquito 
bite, and the rapid migration of sporozoites allows them to escape clearance by local tissue 
 phagocytic cells and to enter lymphatics and blood vessels. Via the blood, sporozoites  rapidly 
reach the liver and, after gliding on HSPG in liver sinusoids, they use circumsporozoite 
 protein (CSP) and thrombospondin-related anonymous protein (TRAP) to bind to KCs. 
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KCs are the potent target of Leishmania donovani amastigotes; early studies identified this on 
the basis of KCs characteristic morphology and anatomical position within the sinusoids 
[114, 115]. In these processes, hepatocytes infection is through KCs [116], indicating that these 
parasites use KCs to overcome the sinusoidal barrier and, ultimately, to infect hepatocytes. 
TREM2 expression by KCs appears to be an important determinant in resistance to  liver-stage 
infection against Plasmodium parasites [117]. Once invading a hepatocyte, the parasites 
develop into merozoites, which will be released from the liver to infect erythrocytes [118]. 
Taken together, these data show that sporozoites not only use their migratory capacity to 
escape elimination by phagocytic and immune cells but also interact with and use KCs to 
increase their efficiency at infecting hepatocytes. 
3. Kupffer cells in fatty liver disease
KCs have been implicated in various liver diseases with different etiologies that are associ-
ated with metabolic complications, such as over-nutrition, and may lead to fatty liver disease. 
Nonalcoholic fatty liver diseases (NAFLDs) are a series of disorders that include nonalcoholic 
fatty liver (NAFL), steatosis with inflammation, and nonalcoholic steatohepatitis. NAFLD 
could cause insulin resistance and is known to increase morbidity and mortality, particularly 
due to an increased cardiovascular risk [119–121]. KCs, liver-resident macrophages, display 
a critical mediator in the development of NAFLD. PAMPs and DAMPs are well known to 
be able to activate various Toll-like receptors (TLR) such as TLR2, 4, and 9 present on KCs, 
by recruiting MyD88 and engaging MAP kinases and activating NF-κB signaling, and could 
be responsible for the inflammatory reaction at different disease stages. Obese and steatotic 
patients corroborate the observation highlighting an increased CD68 mRNA of KCs with 
obesity, and upregulation of many other genes such as chemoattractant protein-1 (MCP-1), 
which is also named chemokine ligand 2 (CCL2). So CCR2-deficient animals show decreased 
steatosis. Soluble CD163 would also correlate with nonalcoholic fatty liver disease activity 
and fibrosis. Deletion of ED2-positive KCs by GdCl3 or clodronate attenuates pro-inflamma-
tory and profibrogenic cytokines release, thereby protecting fatty livers from progression to 
NAFLD [122–125]. 
More recently, it was shown that over-expression of CD14, a coreceptor of TLR4, in KCs of 
mice with high-fat diet (HFD)-induced steatosis increased the hypersensitivity to low-dose 
LPS [126]. TLR4 in KCs mediates the progression of simple steatosis to NAFLD, by induc-
ing ROS-dependent activation of X-box–binding protein-1 [127]. When KCs are activated by 
LPS through TLR4, they display an M1 TNF-expressing pro-inflammatory phenotype and 
increase triglyceride accumulation, decrease fatty acid oxidation and insulin responsiveness 
of hepatocytes. KC-derived TNF production seems to be central in NAFLD development, 
when silencing liver TNF or using TNFR1/2-deficient mice attenuating liver steatosis com-
pared with wild-type mice [128, 129]. 
NOD-like receptors of KCs (NLRs) are intracellular PRRs that are part of the inflammasomes 
briefly mentioned above. Inflammasomes are multiprotein complexes that through NLRs 
sense intracellular danger signals and initiate an activation cascade of events that culminate 
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with autoactivation of caspase 1 and cleavage of promoting IL-1κ and IL-18 production. By 
controlling the release of these important inflammatory cytokines, inflammasomes play an 
important role in the inflammatory process underlying NAFLD [130]. 
Interestingly, it was recently shown that IL-10 released by activated KCs stimulated apoptotic 
death of pro-inflammatory cells [131]. This mechanism mediated resistance to  hepatocyte 
steatosis and subsequently death. Fatty liver disease mechanism caused by excessive alco-
hol consumption is similar as NAFLD. In the same way, the depletion of KCs in mice also 
attenuates alcohol-induced diseases. Then it demonstrated a central role of KCs in fatty liver 
diseases [132].
4. Kupffer cells in liver fibrosis
Fibrogenesis development has many pathological factors, such as inflammation derived from 
Kupffer cells, angiogenesis, and hepatic stellate cell (HSC) activation, and interacts with each 
other, leading to collagen deposition. Cirrhosis is the most advanced stage of fibrosis, with 
septa and nodule formation being the most notable features [133]. KCs or resident hepatic 
macrophages carry out an important role in modulating inflammation in liver fibrosis 
 development. KCs produce reactive oxygen species, a variety of pro-inflammatory cytokines, 
such as TNF-α, IL-1β, and macrophage inflammatory protein (MIP)-1, which could provoke 
HSC activation to produce pro-fibrotic cytokines TGF-β and platelet-derived growth factor 
(PDGF) and subsequently contribute to hepatic injury [134, 135]. 
The accumulation of circulating Ly6Chi monocytes within the liver is greatly dependent on 
CCR2/CCL2 and CCL1/CCR8 axis, in the pathogenesis process, KCs also express multiple 
chemokines and matrix metalloproteinases (MMP-9, -12, and -13) that recruit immune cells 
and promote extracellular matrix degradation, thus favoring the resolution of fibrosis [136]. 
Then, senescent hepatocytes and NF-κB-inducing kinase (NIK) activation in hepatocytes lead 
to the release of numerous chemokines. These chemokines can influence the migration or 
 activation state of macrophages that in turn induce hepatocyte apoptosis. Accordingly, the 
NIK in vivo triggers massive liver inflammation and hepatocyte apoptosis leading to liver 
fibrosis. The fact that on the basis of above experiments KCs depletion using clodronate 
reversed NIK-induced damage [137, 138]. 
Some studies indicate that activating CX3CR1 on KCs increases their IL-10 expression and 
reduces their TNF and TGF-β [139], IL-10 is a potent anti-inflammatory mediator that has 
been shown to inhibit the production of TNF-α and IL-1 and to suppress the activation of 
NF-κB . IL-10 reduces macrophage production of nitric oxide (NO) and reactive oxygen inter-
mediates, and also reduces the expression of adhesion molecules and chemokines [140, 141]. 
Thus, fractalkine (the ligand of CX3CR1) represents a negative feedback on the extension of 
liver inflammation through affecting KCs. 
An antifibrotic effect of liver macrophages was also demonstrated when macrophage infiltra-
tion was blocked during the induction of fibrogenesis in rats. Delta-like ligand 4 (Dll4) is a kind 
of antifibrotic factor. It was expressed in patients’ KCs and liver sinusoidal endothelial cells. 
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In vitro, rDll4 significantly decreased lipopolysaccharide-dependent chemokine expression 
in both KCs and HSCs. Then the inflammatory cell infiltration and their chemokine ligand 2 
(CCL2) expression were significantly reduced in rDll4-receiving bile duct ligation mice. Dll4 
expression was inversely associated with CCL2 abundance. Mechanistically, Dll4 regulated 
CCL2 expression via NF-κB. Taken together, Dll4 modulates liver inflammatory response by 
downregulating chemokine expression and then participates in the role of antifibrosis of liver 
[142, 143]. With regard to recovery from fibrosis, KCs and macrophages secrete proteinases 
that promote the degradation of scarring extracellular matrix proteins. 
5. Kupffer cells in liver ischemia-reperfusion injury
Liver ischemia reperfusion (I/R) injury refers to the paradoxic aggravation of ischemic liver 
resulting from the return of blood flow and oxygen delivery, which is encountered frequently 
in a variety of clinical situations, including liver transplantation, trauma, hepatic resection, or 
hypovolemic shock. If hepatic I/R injury progresses out of control, it can lead to liver failure, 
systemic inflammatory response syndrome, and multiple organ failure, and lastly leading to 
death [144, 145]. Oxidative stress is the major contributor for I/R-induced injury, so the thera-
peutic strategies to antioxidants have gained interest. In I/R injury, KC activation is presumed 
to occur first, resulting in generation of reactive oxygen species (ROS) and preinflammatory 
cytokines such as TNF-α, IL-1β, nitric oxide, and chemokines, which contribute to hepatocyte 
death, endothelial damage and recruitment, and activation of leukocytes [146]. 
KCs secrete CCL2 to promote CCR2-expressing neutrophil recruitment from the bone  marrow 
and subsequent infiltration into the liver during I/R [147], and secrete matrix metalloprotein-
ases (MMPs) to increase graft dysfunction [148]. In this process, platelets could be adherent 
to the KCs, which reflect the activation of KCs and lead to leukocyte accumulation affecting 
sinusoidal perfusion, causing liver failure [149].
Large amounts of endotoxin contact KCs through the portal circulation following IR after 
liver transplantation. The LPS first binds to CD14, triggering KCs activation, then integrates 
with TLR4, and further increases the expression of CD14, the activation signals are trans-
duced into cytoplasm, resulting in NF-κB nuclear translocation and cytokines such as TNF-α 
and IL-6 release, harming the liver graft. TLR4 knockout mice are protected from endothelial 
overactivation in the absence of KCs after IR injury [150]. At the same time, endoplasmic 
reticulum (ER) stress of KCs in evoking liver inflammation following reperfusion contributed 
to the conversion of natural Tregs to Th17 cells due to IL-6 release, resulting in liver injury 
[151]. Whereas the inhibition of high-mobility group box 1 production by KCs after I/R in 
rats could prevent liver injury [152], suppression of TNF-α–mediated apoptotic signaling by 
glutathione (GSH) pretreatment can attenuate hepatic I/R injury in young and aged rats [153]. 
In IR injury, activated KCs could produce pro-inflammation cytokine IL-18, blocking of IL-18 
by IL-18-binding protein may inhibit KCs activation, resulting in a reduction of KC-derived 
harmful stimuli, then ameliorates I/R injury [154]. KCs also could protect liver grafts against 
liver-transplant–induced I/R injury. The protection appears to be mediated by the release 
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of anti-inflammatory IL-10 and the production of antioxidant heme oxygenase by KCs [41, 
155]. The IL-10 secreted by KCs controls pro-inflammatory mediators released from LSEC in 
response to LPS challenge, KCs depletion has also been shown to impair hepatic IL-10 produc-
tion after partial hepatectomy. Pretreatment with IL-10 protects steatotic livers undergoing 
I/R, and that active KCs retain a hepatoprotective role in the steatotic environment [156, 157].
Heme oxygenase-1 (HO-1) is a rate-limiting enzyme of heme degradation, exerts antioxida-
tive, antiapoptotic, anti-inflammatory, and vasoactive effects through its byproducts or itself. 
HO-1 and its byproducts (CO, biliverdin, and iron ion) induction could protect the graft from 
IR injury after liver transplantation in several experimental studies [158]. Our study also has 
the same results. Our results of immunofluorescence also demonstrated that preconditioning 
with Nodosin perfusion induced HO-1 expression mainly in KCs at 24 h after transplantation 
[159] (Figure 3). HO-1 upregulation in KCs plays a protective role in modulating immune 
responses of I/R-injured tissues, or reducing apoptosis induced directly by TNF-α [160]. 
Preincubation of KCs with CO upregulated heat-shock protein 70 (HSP70) and inhibited 
ROS generation. CO-pretreated liver grafts showed less upregulation of TNF-α and induc-
ible nitric oxide synthase messenger RNA (mRNA), reduced expression of pro-apoptotic B 
cell lymphoma 2-associated X protein mRNA, cleaved caspase-3, and poly(adenosine diphos-
phate ribose) polymerase. So, pretreatment of donors with CO ameliorates LT-associated I/R 
injury with increased hepatic HSP70 expression, particularly in the KCs population [161].
6. Kupffer cells in liver transplantation immunology
Liver transplantation is an effective treatment for advanced liver diseases, but immune rejec-
tion is a major obstacle after transplantation. KCs not only can engulf and kill pathogenic 
microorganisms, rid of endotoxin, but also have effects of antigen presentation, secretion of 
cytokines, and immune regulation. They can express high levels of MHC and costimulatory 
molecules and are capable of activating naive T cells [17]. At the same time, they could be 
Figure 3. Immunofluorescence double staining for cellular localization of heme oxygenase 1 (HO-1) expression in the 
rat liver after nodosin perfusion. Liver sections are stained for HO-1 (green) and the Kupffer cell marker ED2 (red). 
Colocalization of these two colors can be recognized by the yellow color. (a) Control group; (b) Nodosin group; (x40) [165].
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activated by antigen to produce T1 cytokines IL-2, IL-1, IL-6, TNF-α, and IFN-γ. They interact 
with the recipient T cells that migrate into the graft and play an important role in immune 
response [162]. Furthermore, the replacement of KCs by recipient bone marrow-derived cells 
(BMDCs) was observed in the liver graft, and functional inhibition of KCs by GdCl3 abrogated 
prolonged survival. Analysis of mRNA expression levels in liver grafts showed a shift of the 
Th1/Th2 balance toward reducing rejection in the BMC groups. So replacement of KCs by 
recipient BMDCs may play an important role in this mechanism of inhibiting rejection [163]. 
After liver transplantation, the reduction of B7 expression in donor KCs could suppress the 
activation of recipient T lymphocytes and secretion of IL-2 via the CD28/B7 costimulatory 
pathway and may induce immune tolerance [164]. The cytokines TNF-α expression in KCs is 
a marker of activated KCs after transplantation and it may be a good target for reversing acute 
rejection post transplantation [165]. GdCl3 depletion of KCs also plays a protective role in liver 
transplantation through suppressing bile duct cell apoptosis, including decreasing expression 
of ALT, ALP, TBIL, and TNF-α, and suppressing Fas-FasL-Caspase signal transduction [166].
KCs not only play a role in immune response directly but also activate the immature DCs or 
recruit immature DCs to liver to mature DCs to take part in immune response, by producing 
pro-inflammation cytokines and chemokines .Then, mDCs could express costimulatory mol-
ecules highly and present antigen to T cells [167, 168].
Recently, it has found that KCs can induce T lymphocyte apoptosis and play an important role 
in the regulation of liver transplantation tolerance. They also could produce high levels of Th2 
cytokines IL-10 and TGF-β and low levels of IL-12 to protect the graft [169]. Although KCs can 
promote immature DCs to mature DCs as immunogenic APCs, they are frequently accompa-
nied by an upregulation of PD-L1 [170], release of IL-10 and TGF-β [171], prostaglandin E2 
(PGE2) [172], IDO [173, 174] and/or arginase [175], which inhibit DC-mediated T cell activa-
tion within the sinusoids, and the presentation of high-affinity peptide by KCs results in the 
deletion of CD8+ T cell tolerance. Furthermore, they promote the suppressive capacity of Tregs 
(CD4+CD25+FoxP3+ T cells) toward hepatic antigens to induce tolerance [176]. KCs could also 
recruit TH17 cells and also γδ T cells are facilitated by CCR6 and possibly also CCR4 via CCL17, 
CCL22, and CCL20. A broad variety of chemokine receptors have been linked to Treg cell migra-
tion (e.g., CCR1, CCR4, CCR5, and CCR6) showing a functional tolerance [28]. KCs mediate 
CD8+ T cells apoptosis by expressing Fas ligand (FasL), which can ligate Fas on CD8+ T cells 
[177]. V-set and Ig domain-containing 4 (VSIG4, CRIg, or Z39Ig), a newly identified B7-related 
cosignaling molecule, exclusive expression on liver KCs is a complement receptor for C3b and 
iC3b and a coinhibitory ligand that negatively regulates T-cell immunity, VSIG4+ KCs play a 
critical role in the induction and maintenance of liver T- and NKT-cell tolerance [178]. So, KCs 
have a dual effect after liver transplantation immunology
7. Kupffer cells in liver cancer and metastases
Persistent hepatic inflammation resulting from hepatitis B or C virus infections (HBV or 
HCV, respectively), NAFLD, or alcohol abuse is a hallmark feature of chronic liver  diseases 
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and appears to be an essential prerequisite of hepatocarcinogenesis. The results of this 
activation involve the production of multiple inflammatory cytokines, ROS, growth con-
trol mediators, various chemokines, which orchestrate the interaction between paren-
chymal and nonparenchymal liver cells, especially KCs to be activated in the process of 
hepatic carcinogenesis. They are also involved in the enhancement of clonal expansion of 
preneoplastic cells, then leading to neoplasia [179]. In diethylnitrosamine-induced HCC 
in mice, pro-inflammatory activation of KCs during the early stages of chemical-induced 
carcinogenesis is important in tumor development. Then, the antitumor effects of KCs are 
widely studied, such as to release TNF-α and iNO to recruit cytotoxic T cells and NK cells, 
to induce apoptosis of cancer cells and phagocytose cancer cells [180]. And some studies 
demonstrated that the expression of TREM-1 by mouse KCs plays a crucial role in their 
activation upon the recognition of necrotic hepatocytes and tumor cells [181]. Activated 
KCs suppress tumor cells through the ADCC pathway via FcγRIII (CD16) and directly 
or indirectly by cytokines. The existence of CD16a in KCs and that the activation of KCs, 
which mainly resulted in CD16a expression, then via NK cells, mediated ADCC reactions 
to induce NK cell cytotoxicity to tumor cells. 
The activated KCs kill target cells directly by swallowing and releasing lysosomal enzyme, 
NO, and peroxidase; they also cooperate to resist tumor cells by secreting cytokines including 
TNF-α, IL-1, IL-6, and granulocyte-macrophage colony-stimulating factor (GM-CSF) [182, 183]. 
IL-6 is highly produced by KCs, it has been related with tumor progression and angiogen-
esis in several tumors, and it is overproduced in HCC. So decreasing the IL-6 production by 
KCs inhibits hepatocellular carcinoma growths [184]. KCs derived from male but not female 
SART1+/− mice produced increased levels of the hypoxia inducible factor (HIF-1)-dependent 
chemokine (RANTES) and cytokine promoting oxidative damage and inflammation, driving 
progression to hepatocellular carcinoma. Reventing inappropriate HIF-1 activation in male 
mice, as a novel therapeutic target for hepatocellular carcinoma [185, 186].
KCs play an essential function in the host tumoral surveillance system. Their strategic posi-
tion in liver allows them to discriminate and remove neoplastic cells that develop in liver. 
Besides primary liver cancer, liver metastases are frequently observed, especially in gastro-
intestinal malignancies. The metastatic cells migrate via the bloodstream into the portal cir-
culation, and they are entrapped in the liver sinusoids [187]. KCs play an important role in 
tumor growth, angiogenesis, and metastasis through the production of a number of growth 
factors (PDGF-β, vascular endothelial growth factor (VEGF), TGF-β, and EGFR ligands), 
cytokines (IL-6, TNFα, and IL-10), chemokines (CCL17, CCL22, CCL24, CXCL12, and IL-8), 
as well as other soluble factors (MMPs, osteopontin, and cyclooxyganse-2). In the liver, CEA 
binds with heterogeneous nuclear RNA-binding protein M (hnRNP M) receptor on KCs 
and causes activation and production of pro- and anti-inflammatory cytokines including 
IL-1, IL-10, IL-6, and TNF-α. These cytokines affect the upregulation of adhesion molecules 
on the hepatic sinusoidal endothelium and protect the tumor cells against cytotoxicity by 
nitric oxide (NO) and other reactive oxygen radicals. This activation is the key to the role of 
CEA in liver metastasis. A large number of clinical studies have shown correlations between 
serum CEA levels and advanced colorectal cancer, in particular, in the presence of liver 
metastasis [188]. 
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KCs were found to have promoted tumor invasion and exacerbated the metastasis and they 
are responsible for the accumulation of liposomes. In the metastatic hepatic cancer, KCs tak-
ing up liposomes were significantly increased, and PEGylated can reverse this result through 
a reduction in tumor-supportive KCs [189]. Primary pancreatic tumor cells release exosomes 
that contain migration inhibitory factor (MIF) into the blood circulation. These PDAC-derived 
exosomes are selectively taken up by liver KCs, leading to the MIF-dependent production 
of fibrotic cytokines by KCs. These fibrotic cytokines, particularly TGF-β, activate liver 
HSCs to produce fibronectin. Deposition of fibronectin in the liver leads to the formation of 
a fibrotic microenvironment that promotes the recruitment of bone marrow-derived cells. 
These sequential events establish a premetastatic niche, which permits the survival and pro-
liferation of disseminated PDAC cells and the formation of metastases in the liver [190]. Some 
studies demonstrated that KCs could help metastatic cancer cells extravasate from vessel via 
CXCL12/CXCR4 pathway. 
KCs in liver can interact with myeloid-derived suppressor cells (MDSCs) and cause their upreg-
ulation of PD-L1, a negative T cell costimulatory molecule, and ultimately lead to tumor immu-
nosuppression in accordance with further tumor progression and metastasis. They can suppress 
CD8+ T cells function via B7-H1/programmed death-1 interactions, which diminishes antitumor 
effect of CD8+ T cells. The metastatic tumor cells entering the liver from portal vein triggered 
KCs and mediated also upregulation of vascular endothelial cell adhesion receptors, such as 
E-selectin to help metastatic tumor cells arrest and extravasate [191–193]. KCs themselves are 
controversial, in metastatic colon tumors, the cytokines produced by KCs (IL-12 and IFN-α) are 
indeed important for the activation of NK cells and NKT cells and for preventing tumor liver 
metastases, depletion of KCs by gadolinium chloride or clodronate liposomes increased the 
number of liver metastasis in some reports [194]. Other studies have demonstrated that KCs 
induce Fas expression in colon cancer cells and malignant glioma cells leading to Fas-mediated 
apoptosis and death in the presence of tumor-infiltrating lymphocytes or TNF-α [195]. 
8. Conclusion
Kupffer cells have various functions in liver injury and repair. KCs, as liver-resident macro-
phages, localize within the lumen of the liver sinusoids and are adherent to the endothelial 
cells that compose the blood vessel walls. They are the first immune cells in the liver that come 
in contact with the gut bacteria, gut bacterial endotoxins, and microbial debris derived from 
the gastrointestinal tract that have been transported to the liver via the portal vein. They also 
interact with other hepatic cells to play an essential role in the host defense. They are responsi-
ble for the development of liver diseases including infectious disease, fatty liver disease, liver 
fibrosis and cirrhosis, ischemia and reperfusion injury, liver transplantation immunology as 
well as liver cancer. But KCs express various phenotypes to have various functions. Because 
of the highly overlapping characteristics of these cells, their functions are controversial. The 
complex roles of KCs in both protective and harmful responses make the liver diseases treat-
ment interesting but difficult. So, further efforts should therefore focus on regulatory mecha-
nisms in specific subpopulations of KCs differentiation and function. 
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